U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Purchased by Precision Wealth Strategies LLC

Precision Wealth Strategies LLC grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 5.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,824 shares of the company’s stock after purchasing an additional 137 shares during the quarter. Precision Wealth Strategies LLC’s holdings in U.S. Physical Therapy were worth $239,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of USPH. Vanguard Group Inc. raised its stake in shares of U.S. Physical Therapy by 2.5% in the 4th quarter. Vanguard Group Inc. now owns 1,062,427 shares of the company’s stock valued at $98,954,000 after purchasing an additional 26,224 shares in the last quarter. Chatham Capital Group Inc. raised its stake in shares of U.S. Physical Therapy by 14.5% in the 1st quarter. Chatham Capital Group Inc. now owns 19,400 shares of the company’s stock valued at $2,190,000 after purchasing an additional 2,450 shares in the last quarter. Norden Group LLC raised its stake in shares of U.S. Physical Therapy by 1,841.6% in the 1st quarter. Norden Group LLC now owns 63,938 shares of the company’s stock valued at $7,217,000 after purchasing an additional 60,645 shares in the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in shares of U.S. Physical Therapy by 268.5% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 549 shares of the company’s stock valued at $61,000 after purchasing an additional 400 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in shares of U.S. Physical Therapy by 0.4% in the 1st quarter. Principal Financial Group Inc. now owns 81,736 shares of the company’s stock valued at $9,226,000 after purchasing an additional 346 shares in the last quarter.

U.S. Physical Therapy Price Performance

USPH opened at $83.44 on Tuesday. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. The firm has a market cap of $1.26 billion, a price-to-earnings ratio of 78.72, a price-to-earnings-growth ratio of 4.02 and a beta of 1.39. The company’s 50-day moving average price is $83.36 and its 200 day moving average price is $93.09.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm had revenue of $167.19 million during the quarter, compared to the consensus estimate of $163.34 million. During the same quarter last year, the company posted $0.76 EPS. U.S. Physical Therapy’s revenue for the quarter was up 10.4% on a year-over-year basis. As a group, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.58 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Friday, August 23rd were given a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend was Friday, August 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 166.04%.

Analyst Ratings Changes

USPH has been the topic of a number of recent analyst reports. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Wednesday, October 9th. Finally, Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down previously from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th.

Insiders Place Their Bets

In other news, Director Kathleen A. Gilmartin bought 2,000 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the transaction, the director now owns 18,904 shares in the company, valued at approximately $1,627,445.36. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the transaction, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. This represents a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.70% of the stock is owned by insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.